ArticleAmerican journal of cancer research2024

ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression.

Jing-Pei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.